Omeros (OMER) Non-Current Assets (2010 - 2026)

Omeros (OMER) reported Non-Current Assets of $105.8 million for Q1 2026, down 23.86% on a YoY basis from $139.0 million in Q1 2025, and down 3.77% sequentially from $110.0 million in Q4 2025.

Omeros (OMER) Non-Current Assets (2010 - 2026) Analysis & Trends

Omeros (OMER) has 17 years of Non-Current Assets data on file, last reported at $105.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets fell 23.86% year-over-year to $105.8 million; the trailing twelve-month figure through Mar 2026 stood at $460.6 million (down 21.09% YoY), and the FY2025 full-year result was $110.0 million, down 23.08% from the prior year.
  • Non-Current Assets slipped to $105.8 million in Q1 2026, from $110.0 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $169.0 million in Q3 2022 to a low of $105.8 million in Q1 2026.
  • A 5-year average of $142.0 million and a median of $143.1 million in 2023 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets jumped 449.14% in 2022 and retreated 23.86% in 2026, its largest moves.
  • Tracing OMER's Non-Current Assets over 5 years: stood at $147.7 million in 2022, then gained by 8.55% to $160.4 million in 2023, then retreated by 10.86% to $143.0 million in 2024, then retreated by 23.08% to $110.0 million in 2025, then dropped by 3.77% to $105.8 million in 2026.
  • Business Quant data shows OMER's Non-Current Assets at $105.8 million in Q1 2026, $110.0 million in Q4 2025, and $113.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Omeros 739.31 Mn 739.31 Mn 9.31 Mn 105.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 105.82 Mn
Dec 31, 2025 109.97 Mn
Sep 30, 2025 113.90 Mn
Jun 30, 2025 130.92 Mn
Mar 31, 2025 138.98 Mn
Dec 31, 2024 142.96 Mn
Sep 30, 2024 148.41 Mn
Jun 30, 2024 153.38 Mn
Mar 31, 2024 156.53 Mn
Dec 31, 2023 160.37 Mn
Sep 30, 2023 141.73 Mn
Jun 30, 2023 138.86 Mn
Mar 31, 2023 143.10 Mn
Dec 31, 2022 147.73 Mn
Sep 30, 2022 169.01 Mn
Jun 30, 2022 152.92 Mn
Mar 31, 2022 159.04 Mn
Dec 31, 2021 171.31 Mn
Sep 30, 2021 32.08 Mn
Jun 30, 2021 32.99 Mn